226.19
                                            Schlusskurs vom Vortag:
              $227.37
            Offen:
              $225.6
            24-Stunden-Volumen:
                493.01K
            Relative Volume:
              1.21
            Marktkapitalisierung:
                $8.82B
            Einnahmen:
              $1.24B
            Nettoeinkommen (Verlust:
              $42.23M
            KGV:
              213.39
            EPS:
                1.06
            Netto-Cashflow:
                $150.33M
            1W Leistung:
              -8.79%
            1M Leistung:
              -11.67%
            6M Leistung:
                -23.58%
            1J Leistung:
              -3.05%
            Penumbra Inc Stock (PEN) Company Profile
Firmenname
                  
                      Penumbra Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (510) 995-2486
                    
                Adresse
                  
                      ONE PENUMBRA PLACE, ALAMEDA, CA
                    
                Vergleichen Sie PEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                PEN
                            
                             
                        Penumbra Inc 
                           | 
                    226.19 | 8.87B | 1.24B | 42.23M | 150.33M | 1.06 | 
| 
                         
                          
                                ABT
                            
                             
                        Abbott Laboratories 
                           | 
                    123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 | 
| 
                         
                          
                                BSX
                            
                             
                        Boston Scientific Corp 
                           | 
                    98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 | 
| 
                         
                          
                                SYK
                            
                             
                        Stryker Corp 
                           | 
                    358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 | 
| 
                         
                          
                                MDT
                            
                             
                        Medtronic Plc 
                           | 
                    90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 | 
| 
                         
                          
                                EW
                            
                             
                        Edwards Lifesciences Corp 
                           | 
                    83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 | 
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-08 | Hochstufung | Needham | Hold → Buy | 
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform | 
| 2025-03-14 | Eingeleitet | BofA Securities | Buy | 
| 2025-01-21 | Eingeleitet | UBS | Buy | 
| 2024-12-17 | Eingeleitet | Oppenheimer | Outperform | 
| 2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight | 
| 2024-09-18 | Eingeleitet | Stifel | Buy | 
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform | 
| 2024-07-31 | Herabstufung | Citigroup | Buy → Neutral | 
| 2024-07-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight | 
| 2024-02-23 | Herabstufung | JP Morgan | Overweight → Neutral | 
| 2023-09-06 | Eingeleitet | Morgan Stanley | Equal-Weight | 
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform | 
| 2023-03-29 | Herabstufung | Needham | Buy → Hold | 
| 2023-01-30 | Eingeleitet | Piper Sandler | Overweight | 
| 2022-11-04 | Hochstufung | Citigroup | Neutral → Buy | 
| 2022-10-12 | Eingeleitet | Jefferies | Buy | 
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral | 
| 2022-09-09 | Hochstufung | Needham | Hold → Buy | 
| 2022-07-18 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2022-04-19 | Eingeleitet | Deutsche Bank | Buy | 
| 2022-03-08 | Eingeleitet | Needham | Hold | 
| 2021-09-16 | Eingeleitet | Truist | Buy | 
| 2021-06-04 | Hochstufung | BTIG Research | Neutral → Buy | 
| 2020-12-16 | Herabstufung | BTIG Research | Buy → Neutral | 
| 2020-10-07 | Fortgesetzt | Canaccord Genuity | Buy | 
| 2020-09-29 | Eingeleitet | BTIG Research | Buy | 
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral | 
| 2020-03-05 | Eingeleitet | Citigroup | Buy | 
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy | 
| 2019-05-30 | Hochstufung | JP Morgan | Neutral → Overweight | 
| 2019-05-21 | Eingeleitet | William Blair | Outperform | 
| 2018-10-29 | Fortgesetzt | BofA/Merrill | Buy | 
| 2018-10-08 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2018-02-21 | Eingeleitet | William Blair | Outperform | 
| 2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral | 
| 2015-11-30 | Bestätigt | Canaccord Genuity | Buy | 
| 2015-10-13 | Eingeleitet | Wells Fargo | Outperform | 
                    Alle ansehen
                    
                  
                Penumbra Inc Aktie (PEN) Neueste Nachrichten
What To Expect From Penumbra’s (PEN) Q3 Earnings - Yahoo Finance
Penumbra stock hits 52-week low at 222.24 USD By Investing.com - Investing.com Nigeria
Penumbra’s thrombectomy treatment shows better outcomes for PE patients - Investing.com
Penumbra’s thrombectomy treatment shows better outcomes for PE patients By Investing.com - Investing.com Australia
Penumbra (NYSE: PEN) Reports 472m vs 376m six-minute walk gains with CAVT in STORM-PE - Stock Titan
Penumbra stock hits 52-week low at 222.24 USD - Investing.com
Does Penumbra Inc. stock trade at a discount to peersWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com
Why Penumbra’s Stock Faces a Downward Trend - TipRanks
Is Penumbra Inc. (0P8) stock a buy for dividend portfoliosJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
Why Penumbra Inc. stock fits value portfoliosWeekly Trade Report & Low Risk Entry Point Guides - newser.com
Is Penumbra Inc. stock a contrarian opportunityWeekly Trade Summary & Growth-Oriented Investment Plans - newser.com
How Penumbra Inc. stock reacts to global recession fears2025 Investor Takeaways & Verified Momentum Stock Alerts - newser.com
Should I hold or sell Penumbra Inc. stock in 2025July 2025 Macro Moves & Weekly High Return Opportunities - newser.com
How strong dollar benefits Penumbra Inc. stockJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
Is Penumbra Inc. stock attractive for retirement portfoliosIndex Update & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Penumbra Inc. stock a top hedge fund pickMarket Volume Report & Capital Efficient Trade Techniques - newser.com
Pier Capital LLC Makes New $394,000 Investment in Penumbra, Inc. $PEN - MarketBeat
Custom watchlist performance reports with Penumbra Inc.Chart Signals & Comprehensive Market Scan Reports - newser.com
Why Penumbra Inc. stock is a strong buy callWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will Penumbra Inc. stock attract ESG investorsEntry Point & High Conviction Trade Alerts - newser.com
Strs Ohio Acquires New Position in Penumbra, Inc. $PEN - MarketBeat
Teacher Retirement System of Texas Buys 2,078 Shares of Penumbra, Inc. $PEN - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Penumbra, Inc. $PEN - MarketBeat
Wall Street Zen Downgrades Penumbra (NYSE:PEN) to Hold - MarketBeat
Penumbra Inc Stock Analysis and ForecastHealthcare Stock Analysis & Explosive Profit Growth - earlytimes.in
Penumbra, Inc. (PEN) Stock forecasts - Yahoo! Finance UK
Penumbra, Inc. (PEN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Earnings call transcript: Penumbra’s Q2 2025 performance shows strong growth - Investing.com Canada
Earnings call transcript: Penumbra’s Q2 2025 performance shows strong growth By Investing.com - Investing.com South Africa
Scholtz & Company LLC Raises Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Is Penumbra Inc. stock undervalued vs historical averages2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Brighton Jones LLC Acquires Shares of 1,177 Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors - MSN
Carret Asset Management LLC Sells 2,000 Shares of Penumbra, Inc. $PEN - MarketBeat
Hantz Financial Services Inc. Lowers Position in Penumbra, Inc. $PEN - MarketBeat
Is Penumbra Inc. (0P8) stock a momentum leaderEarnings Growth Summary & Technical Buy Zone Confirmations - newser.com
Why Penumbra Inc. (0P8) stock is a strong buy call2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Penumbra, Inc. (PEN) Stock Forecasts - Yahoo Finance
Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights - TipRanks
Is Penumbra’s Stock Still a Good Bet After a 7% Drop in the Past Month? - Yahoo Finance
Ischemic Neurological Interventional Medical Devices Market - openPR.com
Penumbra Enters Oversold Territory (PEN) - Nasdaq
Why Penumbra (PEN) Shares Are Falling Today - Yahoo Finance
Finanzdaten der Penumbra Inc-Aktie (PEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):